Gut Bacteria and Bowel Recovery in Short Bowel Syndrome
Part of Digestive system clinical trials.
This study looks at how bacteria in your gut help your digestive system adapt after short bowel surgery. Researchers will track your microbiota (the trillions of bacteria in your gut) to understand how it changes and helps your body adjust to having less small intestine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with short bowel syndrome and have a surgically created opening (jejunostomy) that will be reconnected within the next 3 months
- Your remaining small intestine (the lower part after a specific landmark called the ligament of Treitz) is less than about 6.5 feet (200 cm)
- You have more than 14% of your colon (large intestine) remaining and it is healthy with no inflammation, radiation damage, or scarring
- You are enrolled in French social security or have equivalent health coverage
- You are able to understand and communicate in French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at short bowel syndrome in children who have had intestinal surgery. It may help doctors understand how to better treat this condition.
This study tests if adding high-fiber foods can help people with short bowel syndrome (a condition where part of the small intestine is missing or removed). You will be asked to eat fiber-rich foods and the study team will see how your body handles them.
This study looks at how gut bacteria change after surgery to reconnect the intestines (anastomosis). It may help doctors understand complications and improve recovery.
This trial tests if crofelemer can reduce diarrhea and fluid loss in people with short bowel syndrome who have a stoma (no colon connection) and need intravenous nutrition or fluids. The goal is to see if it improves gut function and quality of life.
This study tests a new treatment called FT1 for people with short bowel syndrome. It aims to help you absorb more nutrients and fluids from food, potentially reducing the need for IV nutrition.
This trial studies whether the Eclipse XL1 system is safe and may help people with short bowel syndrome, in both children and adults. It will check how well the approach works and watch for side effects over the study period.
Hear when a new Short Bowel Syndrome (SBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.